Marktanalyse - The Rheumatoid Arthritis Community is Swelling with Anticipation as its Research Pipeline Begins to Burst

The Rheumatoid Arthritis Community is Swelling with Anticipation as its Research Pipeline Begins to Burst


Summary


GlobalData's analysis alert 'The Rheumatoid Arthritis Community is Swelling with Anticipation as its Research Pipeline Begins to Burst”, analyzes the current pipeline for rheumatoid arthritis drug therapeutics. In addition to the anticipated upcoming approval of Pfizer’s tofacitinib, the pipeline has other entities waiting in the wings. Tofacitinib conquers the troublesome formulation issue as it is administered in oral doses, but other compounds are in development in oral form as well. Tofacitinib also tackles the JAK pathway which current RA therapies do not target, and there are other kinase inhibitors in the development pipeline. Also, there is the possibility of a DNA vaccine which will minimize early symptoms of RA. Finally, we look at a new potential pathway to target in order to inhibit inflammation and joint destruction for people suffering from RA.


Scope

- Details of select upcoming RA therapies with clinical trial results.
- Discussion of a possible new pathway which may be involved with the promotion of RA.


Reasons to buy

- Important details of the select RA therapies are discussed along with ACR response results from clinical trials.
- Stay informed about the RA pipeline, which has an abundance of activity, and some unmet needs will be answered in the near future.

1 Table of Contents

1 Table of Contents 1

2 Introduction 1

2.1 Pfizer’s tofacitinib, a JAK 3 Inhibitor 1

2.2 Incyte’s LY3009104, JAK 1, 2 Inhibitor 2

2.3 Immune Response BioPharma, Inc’s RAVAX RA Vaccine 2

2.4 Discovery of a new pathway? 3

2.5 The future of RA Therapy 3

3 Appendix 3

3.1 Methodology 3

3.1.1 Coverage 3

3.1.2 Secondary Research 3

3.1.3 Primary Research 4

3.1.4 Expert Panel Validation 4

3.2 Contact Us 4

3.3 Disclaimer 4

• Calming and Sleeping in Canada
• Calming and Sleeping in Denmark
• Calming and Sleeping in Hong Kong, China
• Calming and Sleeping in Norway
• Calming and Sleeping in Turkey
• Cough, Cold and Allergy (Hay Fever) Remedies in Canada
• Cough, Cold and Allergy (Hay Fever) Remedies in Denmark
• Cough, Cold and Allergy (Hay Fever) Remedies in Hong Kong, China
• Cough, Cold and Allergy (Hay Fever) Remedies in Norway
• Cough, Cold and Allergy (Hay Fever) Remedies in Turkey
• Critical Care Market to 2019 - Growth from Factor Concentrates New Indications and Increasing Demand for Albumin in Asia-Pacific
• Ear Care in Canada
• Ear Care in Denmark
• Ear Care in Hong Kong, China
• Ear Care in Norway
• Emergency Contraception in Canada
• Emergency Contraception in Denmark
• Emergency Contraception in Norway
• Global Vaccine Market
• Health and Beauty Specialist Retailers in Saudi Arabia